Back to Search
Start Over
Two-year crizotinib monotherapy induced durable complete response of pediatric ALK-positive inflammatory myofibroblastic tumor.
- Source :
-
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Aug; Vol. 70 (8), pp. e30330. Date of Electronic Publication: 2023 Apr 05. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 1545-5017
- Volume :
- 70
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Pediatric blood & cancer
- Publication Type :
- Editorial & Opinion
- Accession number :
- 37017194
- Full Text :
- https://doi.org/10.1002/pbc.30330